JPH0234923B2 - - Google Patents

Info

Publication number
JPH0234923B2
JPH0234923B2 JP55092142A JP9214280A JPH0234923B2 JP H0234923 B2 JPH0234923 B2 JP H0234923B2 JP 55092142 A JP55092142 A JP 55092142A JP 9214280 A JP9214280 A JP 9214280A JP H0234923 B2 JPH0234923 B2 JP H0234923B2
Authority
JP
Japan
Prior art keywords
compound
compounds
general formula
salt
administered
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
JP55092142A
Other languages
English (en)
Japanese (ja)
Other versions
JPS5716821A (en
Inventor
Kazuhiro Goto
Michio Terasawa
Masao Kudome
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mitsubishi Tanabe Pharma Corp
Original Assignee
Yoshitomi Pharmaceutical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yoshitomi Pharmaceutical Industries Ltd filed Critical Yoshitomi Pharmaceutical Industries Ltd
Priority to JP9214280A priority Critical patent/JPS5716821A/ja
Publication of JPS5716821A publication Critical patent/JPS5716821A/ja
Publication of JPH0234923B2 publication Critical patent/JPH0234923B2/ja
Granted legal-status Critical Current

Links

Landscapes

  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP9214280A 1980-07-04 1980-07-04 Remedy for disease due to immunological dysfunction Granted JPS5716821A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP9214280A JPS5716821A (en) 1980-07-04 1980-07-04 Remedy for disease due to immunological dysfunction

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP9214280A JPS5716821A (en) 1980-07-04 1980-07-04 Remedy for disease due to immunological dysfunction

Publications (2)

Publication Number Publication Date
JPS5716821A JPS5716821A (en) 1982-01-28
JPH0234923B2 true JPH0234923B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1990-08-07

Family

ID=14046180

Family Applications (1)

Application Number Title Priority Date Filing Date
JP9214280A Granted JPS5716821A (en) 1980-07-04 1980-07-04 Remedy for disease due to immunological dysfunction

Country Status (1)

Country Link
JP (1) JPS5716821A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPWO2024029528A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 2022-08-02 2024-02-08

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1447031A (en) * 1972-05-19 1976-08-25 Wellcome Found Tricyclic sulphones and pharmaceutical compositions containing them

Also Published As

Publication number Publication date
JPS5716821A (en) 1982-01-28

Similar Documents

Publication Publication Date Title
Kaur et al. Dexamethasone‐cyclophosphamide pulse therapy in pemphigus
JPS60193998A (ja) アデノシン誘導体及び該誘導体を含有する抗アレルギー剤
JPH05208908A (ja) 慢性の対宿主移植片疾患治療剤
JPH05507697A (ja) 臓器移植拒絶反応の治療
JPH0261477B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
JPH03181422A (ja) 炎症の治療方法及び炎症の治療用合成薬
Kelley et al. The nephrotic syndrome in children: I. Clinical response to nitrogen mustard therapy
JPS61186322A (ja) 免疾調節剤
JP5336175B2 (ja) 免疫調整剤活性を有する化合物
KR0160538B1 (ko) 안 국부 투여용 항알레르기 약학적 조성물
Takeda et al. Prolonged pseudoaldosteronism induced by glycyrrhizin
JP2746832B2 (ja) 眼局所抗アレルギー剤
US3966944A (en) 10 (N-methyl-4-piperidylidene)-10H[1]-benzopyrano[3,2-b]-pyridine as an analgesic, anti-inflammatory and agent against type III hypersensitivity disease
EP0399051B1 (en) Polyvalent antiinflammatory agent
CA1297033C (en) Use of carboxylic acid amides for treating inflammations
JPH0234923B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
JPH10212246A (ja) 経口投与用製剤
PH26517A (en) Methods and composition for the treatment of psoriasis
US4124718A (en) Enhancing zinc serum and tissue levels
JPH0641411B2 (ja) 免疫調節剤
US3928612A (en) 1,2-Dihydro- and 1,2,3,4-tetrahydro-1-oxo-3-isoquinolinecarboxylic acid derivatives as anti-allergic agents
JP2525787B2 (ja) 腎疾患用薬
US4377586A (en) Diuretic 2,6-diaryl-4-pyridine carboxylic acids
JPS6111A (ja) 脱髄性疾患治療剤
Coulson et al. Generalized pustular psoriasis after renal transplantation‐failure to suppress with cyclosporin A